Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$330,397,188
+$83,578,057 QoQ
Shares Held
1,300,930
+28.8% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#140
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2026CallValue
$1,269,850
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $908,993,306 across 12 Drug Manufacturers - General names. JNJ ranks #1 (36.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,300,930 | $330,397,188 | |
| 2 | LLY |
ELI LILLY & Co
|
136,320 | $163,506,307 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
947,749 | $119,738,606 | |
| 4 | AZN |
Astrazeneca PLC
|
346,381 | $65,680,764 | |
| 5 | AMGN |
Amgen Inc
|
155,115 | $56,170,241 | |
| 6 | ABBV |
AbbVie Inc.
|
198,110 | $49,852,399 | |
| 7 | MRK |
Merck & Co., Inc.
|
385,052 | $49,479,181 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
725,587 | $41,808,321 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $330,397,188 | 1,300,930 | Shares | Defined | 2026-08-03 | |
| 2026-06-30 | $1,269,850 | 5,000 | Call | Defined | 2026-08-03 | |
| 2026-03-31 | $246,819,131 | 1,009,733 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $189,155,194 | 914,014 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $111,655,842 | 602,178 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $82,291,920 | 538,736 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $45,914,460 | 276,860 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $47,211,630 | 326,453 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $55,481,885 | 342,354 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $56,605,134 | 387,282 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $63,581,937 | 401,934 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $64,778,759 | 413,288 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $67,622,442 | 434,173 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $72,919,337 | 440,547 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $67,379,120 | 434,704 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $74,260,478 | 420,382 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $58,775,784 | 359,793 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $64,683,399 | 364,393 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $59,746,181 | 337,111 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $56,184,518 | 328,430 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,854,080 | 308,694 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $40,100,186 | 243,415 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $47,312,583 | 287,877 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $46,503,743 | 295,487 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||